Literature DB >> 16218804

Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.

L A Petch1, I F Hoffman, C S Jere, P N Kazembe, F E Martinson, D Chilongozi, S A Fiscus, M S Cohen.   

Abstract

The protease (PR) and reverse transcriptase (RT) regions of HIV-1 isolates from 21 antiretroviral (ARV)-naive Malawian adults were sequenced and analyzed to determine the prevalence of drug resistance-associated mutations in this population. Phylogenetic analysis confirmed that all isolates grouped with HIV-1 subtype C, the predominant subtype in Malawi. No major mutations associated with resistance to PR inhibitors (PIs), nucleoside RT inhibitors (NRTIs), or nonnucleoside RT inhibitors (NNRTIs) were found. In contrast, accessory mutations were found in the protease region at positions 10, 20, 36, 63, 77, and 93, and in the RT region at positions 118, 211, and 214. Further studies will be needed to determine the clinical impact of these polymorphisms on viral susceptibility to existing antiretroviral drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218804     DOI: 10.1089/aid.2005.21.799

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.

Authors:  Nora E Rosenberg; Gift Kamanga; Sam Phiri; Dominic Nsona; Audrey Pettifor; Sarah E Rutstein; Deborah Kamwendo; Irving F Hoffman; Maria Keating; Lillian B Brown; Beatrice Ndalama; Susan A Fiscus; Seth Congdon; Myron S Cohen; William C Miller
Journal:  J Infect Dis       Date:  2011-12-29       Impact factor: 5.226

2.  Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.

Authors:  Vijay B Bansode; Simon Aa Travers; Amelia C Crampin; Bagrey Ngwira; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Ther       Date:  2011-10-13       Impact factor: 2.250

3.  Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi.

Authors:  Vijay Bansode; Zuzanna J Drebert; Simon A A Travers; Emmanuel Banda; Anna Molesworth; Amelia Crampin; Bagrey Ngwira; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-15       Impact factor: 2.205

4.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

5.  Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Authors:  Vincent C Marconi; Henry Sunpath; Zhigang Lu; Michelle Gordon; Kofi Koranteng-Apeagyei; Jane Hampton; Steve Carpenter; Janet Giddy; Douglas Ross; Helga Holst; Elena Losina; Bruce D Walker; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

Review 6.  The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.

Authors:  Hakim Sendagire; Philippa J Easterbrook; Immaculate Nankya; Eric Arts; David Thomas; Steven J Reynolds
Journal:  AIDS Rev       Date:  2009 Apr-Jun       Impact factor: 2.500

7.  Antibody maturation and viral diversification in HIV-infected women.

Authors:  Maria M James; Oliver Laeyendecker; Jin Sun; Donald R Hoover; Caroline E Mullis; Matthew M Cousins; Thomas Coates; Richard D Moore; Gabor D Kelen; Mary Glenn Fowler; Johnstone J Kumwenda; Lynne M Mofenson; Newton I Kumwenda; Taha E Taha; Susan H Eshleman
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.